Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sichuan University
M.D. Anderson Cancer Center
NYU Langone Health
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Rutgers, The State University of New Jersey
West Virginia University
Maastricht University Medical Center
Hoosier Cancer Research Network
Massachusetts General Hospital
Vanderbilt-Ingram Cancer Center
University of Wisconsin, Madison
Maastricht Radiation Oncology
Shanghai Pulmonary Hospital, Shanghai, China
Mayo Clinic
University of Washington
Hoosier Cancer Research Network
University of Washington
Peking University Cancer Hospital & Institute
Fox Chase Cancer Center
Case Comprehensive Cancer Center
SCRI Development Innovations, LLC
Shandong Cancer Hospital and Institute
Emory University
M.D. Anderson Cancer Center
Independent Public Care Health Facility of the Ministry of the Interior and Warmian & Mazurian Oncology Centre
M.D. Anderson Cancer Center
Institut Cancerologie de l'Ouest
The Christie NHS Foundation Trust
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Peking University People's Hospital
Alliance for Clinical Trials in Oncology
Hoosier Cancer Research Network
Virginia Commonwealth University
University of Kentucky
Stanford University
Trans Tasman Radiation Oncology Group
Trans Tasman Radiation Oncology Group
Clinical Oncology Research Associates
Clinical Oncology Research Associates
Huazhong University of Science and Technology